Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma

Abstract

Tripartite motif-containing protein 35 (TRIM35) is a member of RBCC family, which has a highly conserved order consisting of a RING domain followed by one or two B-Box domains and then a coiled-coil domain. We previously identified TRIM35 as a novel tumor suppressor in human hepatocellular carcinoma (HCC). However, the molecular mechanism that TRIM35 uses to suppress tumorigenicity is largely unknown. Pyruvate kinase isoform M2 (PKM2) has been demonstrated to have a central role in metabolic reprogramming during cancer progression. Phosphorylation of PKM2 tyrosine residue 105 (Y105) regulates PKM2 to provide a metabolic advantage to tumor cells, thereby promoting tumor growth. In the present work, mass spectrometry analysis demonstrated an interaction between TRIM35 and PKM2. Co-IP experiments confirmed that TRIM35 interacts with PKM2 and that the coiled-coil domain is required for such an interaction. Furthermore, the coiled-coil domain mediates decreases in the Warburg effect and in the cell proliferation of HCC cells. In addition, TRIM35 suppresses the tumorigenicity of HCC cells through the blockade of PKM2 Y105 phosphorylation. Collectively, our data reveal a new function for TRIM35, which is to regulate the Warburg effect and tumorigenicity through interaction with PKM2 in HCC.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.

    Google Scholar 

  2. Siegel R, Naishadham D, Jemal A . Cancer statistics. 2013. CA Cancer J Clin 2013; 63: 11–30.

    Article  Google Scholar 

  3. Maluccio M, Covey A . Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 2012; 62: 394–399.

    Article  Google Scholar 

  4. Jia D, Wei L, Guo W, Zha R, Bao M, Chen Z et al. Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma. Hepatology 2011; 54: 1227–1236.

    Article  CAS  Google Scholar 

  5. Kimura F, Suzu S, Nakamura Y, Nakata Y, Yamada M, Kuwada N et al. Cloning and characterization of a novel RING-B-box-coiled-coil protein with apoptotic function. J Biol Chem 2003; 278: 25046–25054.

    Article  CAS  Google Scholar 

  6. Lalonde JP, Lim R, Ingley E, Tilbrook PA, Thompson MJ, McCulloch R et al. HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressor. J Biol Chem 2004; 279: 8181–8189.

    Article  CAS  Google Scholar 

  7. McNab FW, Rajsbaum R, Stoye JP, O'Garra A . Tripartite-motif proteins and innate immune regulation. Curr Opin Immunol 2011; 23: 46–56.

    Article  CAS  Google Scholar 

  8. Hatakeyama S . TRIM proteins and cancer. Nat Rev Cancer 2011; 11: 792–804.

    CAS  Google Scholar 

  9. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452: 230–233.

    Article  CAS  Google Scholar 

  10. Hoshino A, Hirst JA, Fujii H . Regulation of cell proliferation by interleukin-3-induced nuclear translocation of pyruvate kinase. J Biol Chem 2007; 282: 17706–17711.

    Article  CAS  Google Scholar 

  11. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011; 145: 732–744.

    Article  CAS  Google Scholar 

  12. Gao X, Wang H, Yang JJ, Liu X, Liu ZR . Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell 2012; 45: 598–609.

    Article  CAS  Google Scholar 

  13. Yang W, Xia Y, Hawke D, Li X, Liang J, Xing D et al. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 2012; 150: 685–696.

    Article  CAS  Google Scholar 

  14. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011; 480: 118–122.

    Article  CAS  Google Scholar 

  15. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC . Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008; 452: 181–186.

    Article  CAS  Google Scholar 

  16. Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, Lythgoe K et al. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2009; 2: ra73.

    Article  Google Scholar 

  17. Freeman KW, Gangula RD, Welm BE, Ozen M, Foster BA, Rosen JM et al. Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation. Cancer research 2003; 63: 6237–6243.

    CAS  PubMed  Google Scholar 

  18. Welm BE, Freeman KW, Chen M, Contreras A, Spencer DM, Rosen JM . Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. The Journal of cell biology 2002; 157: 703–714.

    Article  CAS  Google Scholar 

  19. Clackson T, Yang W, Rozamus LW, Hatada M, Amara JF, Rollins CT et al. Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity. Proc Natl Acad Sci USA 1998; 95: 10437–10442.

    Article  CAS  Google Scholar 

  20. Endersby R, Majewski IJ, Winteringham L, Beaumont JG, Samuels A, Scaife R et al. Hls5 regulated erythroid differentiation by modulating GATA-1 activity. Blood 2008; 111: 1946–1950.

    Article  CAS  Google Scholar 

  21. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E . Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005; 15: 300–308.

    Article  CAS  Google Scholar 

  22. Dombrauckas JD, Santarsiero BD, Mesecar AD . Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 2005; 44: 9417–9429.

    Article  CAS  Google Scholar 

  23. Lv L, Li D, Zhao D, Lin R, Chu Y, Zhang H et al. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell 2011; 42: 719–730.

    Article  CAS  Google Scholar 

  24. Lee J, Kim HK, Han YM, Kim J . Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int J Biochem Cell Biol 2008; 40: 1043–1054.

    Article  CAS  Google Scholar 

  25. Yang W, Zheng Y, Xia Y, Ji H, Chen X, Guo F et al. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 2012; 14: 1295–1304.

    Article  CAS  Google Scholar 

  26. Yang W, Lu Z . Nuclear PKM2 regulates the Warburg effect. Cell cycle 2013; 12: 3154–3158.

    Article  CAS  Google Scholar 

  27. He HC, Ling XH, Zhu JG, Fu X, Han ZD, Liang YX et al. Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation. Mol Biol Rep 2013; 40: 3799–3805.

    Article  CAS  Google Scholar 

  28. Figeac N, Serralbo O, Marcelle C, Zammit PS . ErbB3 binding protein-1 (Ebp1) controls proliferation and myogenic differentiation of muscle stem cells. Dev Biol 2014; 386: 135–151.

    Article  CAS  Google Scholar 

  29. Baek YM, Hwang HJ, Kim SW, Hwang HS, Lee SH, Kim JA et al. A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SK-N-SH) cells. Proteomics 2008; 8: 4748–4767.

    Article  CAS  Google Scholar 

  30. Vander Heiden MG, Plas DR, Rathmell JC, Fox CJ, Harris MH, Thompson CB . Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol Cell Biol 2001; 21: 5899–5912.

    Article  CAS  Google Scholar 

  31. Ashcroft SJ, Weerasinghe LC, Bassett JM, Randle PJ . The pentose cycle and insulin release in mouse pancreatic islets. Biochem J 1972; 126: 525–532.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful for Dr T Didier’s gifts of the pWPXL, psPAX2 and pMD2.G lentivirus plasmids. We thank Qunying Lei for discussions throughout this study. We thank Jianhua Zhu for use of the scintillation counter. We thank Feng Wang and Ping Zhang for technical assistance. This work was supported by grants from the National 973 Key Basic Research Program (2013CB910504), Shanghai Natural Science Fund for Youth Scholars (12ZR1449900), Shanghai Rising-Star Program (12QA1403100), Shanghai ‘Promising Youth Medical Worker’ Project (XYQ2011042), National Natural Science Foundation of China (81201538, 81125016, 81171942).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to X He.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Z., Wang, Z., Guo, W. et al. TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma. Oncogene 34, 3946–3956 (2015). https://doi.org/10.1038/onc.2014.325

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2014.325

This article is cited by

Search

Quick links